期刊文献+

miR-199a通过靶向ATP13A2抑制6-OHDA诱导的PC12细胞氧化应激 被引量:4

MiR-199a inhibits 6-hydroxydopamine induced oxidative stress in PC12 cells by targeting ATP13A2
下载PDF
导出
摘要 目的:探究miR-199a通过靶向调节ATP13A2对6-OHDA诱导的PC12细胞氧化应激的影响。方法:收集正常大鼠和帕金森(PD)模型大鼠脑组织,培养6-OHDA诱导的PC12细胞,利用Real-time PCR检测miR-199a和ATP13A2的表达,Western Blot检测ATP13A2表达。分别转染miR-199a类似物和miR-199a抑制剂,利用ELISA检测ROS、MDA、SOD和GSH-Px的表达。双荧光素酶报告基因检测miR-199a与ATP13A2的靶向关系。Western Blot法检测ATP13A2和JNK/c-Jun表达的影响。MTT法检测细胞增殖的影响。结果:PD脑组织和细胞中miR-199a表达显著降低,ATP13A2表达显著升高(P<0.01)。过表达miR-199a可显著降低6-OHDA诱导的PC12细胞的ROS、MDA活性,升高SOD、GSH-Px活性(P<0.01)。miR-199a过表达显著降低荧光素酶报告基因的荧光强度,而结合位点突变后荧光素酶活性不变(P<0.01)。过表达miR-199a显著降低ATP13A2的表达并抑制JNK和c-Jun的磷酸化水平,茴香霉素则升高ATP13A2表达并激活JNK和c-Jun的磷酸化水平,过表达miR-199a且给予茴香霉素处理可使JNK和c-Jun的磷酸化水平恢复到6-OHDA-PC12组水平(P<0.01)。过表达miR-199a抑制6-OHDA诱导的PC12细胞增殖,茴香霉素则促进其增殖,过表达miR-199a且给予茴香霉素处理可使细胞增殖率恢复到6-OHDA-PC12组水平(P<0.01)。结论:miR-199a可通过靶向调节ATP13A2抑制6-OHDA诱导的PC12细胞氧化应激并抑制JNK/c-Jun活化。 Objective: To investigate the role of miR-199a on the 6-hydroxydopamine (6-OHDA)-induced oxidative stress in PC12 cells by targeting ATP13A2. Methods: Brain tissues of normal rat and Parkinson disease (PD) model rat were collected, and the PC12 ceils treated with 6-OHDA were cultured. The levels of miR-199a and ATP13A2 were detected by Real-time PCR analysis, the protein level of ATP13A2 was detected by Western Blot analysis. PC12 cells were transfected with miR-199a inhibitor and treated with miR-199a inhibitor respectively. The expressions of ROS, MDA, SOD and GSH-Px were measured by ELISA analysis. Then, the target relationship of miR-199a and ATP13A2 was determined by dual-luciferase reporter gene assay. In addition, the effects of miR-199a on the ATP13A2 and JNK/c-Jun expressions were assessed by Western Blot analysis. The role of anisomycin on ceils proliferation was detected by MTr assay. Results: The expression levels of miR-199a were significantly decreased and ATP13A2 was increased in PD brain tissues and cells (P 〈 0.01 ). And, miR-199a overexpression remarkably decreased the ROS, MDA levels and increased the SOD, GSH-Px levels in the PC12 cells treated with 6-OHDA (P 〈 0.01 ). The results showed that the relative luciferase activity was significantly decreased in PC12 cells transfected with miR-199a mimics, but the fluorescence activity was not changed after the binding site mutation (P 〈 0.01 ). Overexpression of miR-199a decreased the ATP13A2 expression and reduced the JNK and c-Jun phosphorylation levels, but anisomycin increased the ATP13A2 expression and activated the JNK and c-Jun phosphorylation levels (P 〈 0.01 ). The phosphorylation levels of JNK and c-Jun were restored to the expressions in 6-OHDA-PC12 group by co-treatment of miR-199a overexpression and anisomycin. MiR-199a overexpres- sion inhibited the 6-OHDA induced the PC12 cells proliferation, while anisomycin promoted the cells proliferation. More- over, the cells proliferation rate was restored to the rate in the 6-OHDA-PC12 group by co-treatment of miR-199a overex- pression and anisomycin (P 〈 0.01 ). Conclusion: MiR-199a inhibited 6-OHDA induced oxidative stress in the PC12 cells by targeting ATP13A2 and down-regulated the JNK/c-Jun activation.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2016年第6期691-697,共7页 Chinese Journal of Neuroanatomy
基金 国家自然科学基金(81171135)
关键词 miR-199a 帕金森病 ATP13A2 PC12 细胞 miR-199a PD ATP13A2 PC12 cell
  • 相关文献

参考文献9

二级参考文献189

  • 1师亮,张宇新,张作凤,陈浩.COX-2对帕金森病小鼠黑质内多巴胺能神经元的毒性作用[J].第四军医大学学报,2006,27(18):1661-1664. 被引量:9
  • 2Xiromerisiou G, Dardiotis E, Tsimourtou V, et al. Genetic basis of Parkinson disease [ J ]. Neurosurg Focus, 2010, 28: E7.
  • 3Lesage S, Briee A. Parkinson's disease: from monogenic forms to genetic susceptibility factors[ J ]. Hum Mol Genet, 2009, 18:48-59.
  • 4Mao XY, Burgunder JM, Zhang ZJ, et al. ATP13A2 G2236A variant is rare in patients with early-onset Parkinson's disease and familial Parkinson's disease from China's Mainland [J]. Parkinsonism Relat Disord, 2010, 16:235 - 236.
  • 5Ramirez A, Heimbach A, Grttndemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13 A2, encoding a lysosomal type 5 P-type ATPase [ J ]. Nature Genet, 2006, 38:1184- 1191.
  • 6Vilarino-Guell C, Soto AI, Lincoln SJ, et al. ATP13A2 variability in Parkinson disease [ J ]. Hum Mutat, 2009, 30:406 - 410.
  • 7Williams DR, Hadeed A, al-Din AS, et al. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia [ J ]. Mov Disord, 2005, 20:1264 - 1271.
  • 8Di Fonzo A, Chien HF, Soeal M, et al. ATP13A2 mis- sense mutations in juvenile parkinsonism and young onset Parkinson disease[ J ]. Neurology, 2007, 68 : 1557 - 1562.
  • 9Ning YP, Kanai K, Tomiyama H, et al. PARKg-linked parkinsonism in eastern Asia: mutation detection in ATPI3A2 and clinical phenotype [J]. Neurology, 2008, 70:1491 - 1493.
  • 10Camargos ST, Dornas LO, Momeni P, et al. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations [J]. Mov Disord. 2009.24:662 - 666.

共引文献21

同被引文献29

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部